nERβ5 may have an oncogenic role, wherease cERβ5 may have anti-oncogenic role in ovarian cancer, yet, we detected activation of cytoplasmic tyrosine kinases FAK/c-Src by ERβ5. The gene discussed is SRC; the disease is ovarian cancer.